D59.2 Drug-induced nonautoimmune hemolytic anemia
The ICD-10-CM code for Drug-induced nonautoimmune hemolytic anemia is D59.2 (FY2026). It is a billable, claim-ready diagnosis code.
Classification
- Section
- D55-D59: Hemolytic anemias (D55-D59)
- Category D59
- 19 codes (16 billable)
- FY2026 Status
- Stable since FY2024
Also Known As
ICD-10-CM Alphabetic Index entries that lead to D59.2:
- Nonautoimmune hemolytic anemia › drug-induced
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) › enzyme-deficiency, drug-induced
- Disease, diseased › nonautoimmune hemolytic › drug-induced
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) › hemolytic › due to › drugs (nonautoimmune)
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) › deficiency › enzyme › drug-induced (hemolytic)
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) › hemolytic › nonautoimmune › drug-induced
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) › hemolytic › due to › enzyme disorder › drug-induced
Inclusion Terms
- Drug-induced enzyme deficiency anemia
U.S. Hospital Utilization
- An estimated 580 U.S. inpatient stays in 2023 included D59.2 among the documented diagnoses.
- 200 stays listed it as the principal diagnosis.
Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.
Official Coding Guidelines
Chapter 3 TOC entry3. Chapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) ............................................................................................. 39
Reserved for future guideline expansionReserved for future guideline expansion ...................................................................................... 39
Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026